Due to the fact Pirfenidone is metabolised through the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is likely to precipitate the toxicity of pirfenidone: concomitant therapy should be to be avoided. More monitoring and dosage adjustment might be wanted in accordance with solution labeling of CYP1A2 substrates. seventy https://tris24-di-tert-butylpheny77553.ttblogs.com/9241140/dapagliflozin-fundamentals-explained